Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2014 (2014), Article ID 526979, 6 pages
http://dx.doi.org/10.1155/2014/526979
Research Article

Nonalcoholic Fatty Liver Disease: Different Classifications Concordance and Relationship between Degrees of Morphological Features and Spectrum of the Disease

1Postgraduate Program, Department of Pathology, University Hospital, Faculty of Medicine, Federal University of Rio de Janeiro, Avenida Prof. Rodolpho Paulo Rocco 255, Cidade Universitária, 21941-913 Rio de Janeiro, RJ, Brazil
2Faculty of Medicine, Severino Sombra University, Avenida Expedicionário Oswaldo de Almeida Ramos 280, Centro, 27700-000 Vassouras, RJ, Brazil
3Department of Pathology, University Hospital, Faculty of Medicine, Federal University of Rio de Janeiro, Avenida Prof. Rodolpho Paulo Rocco 255, Cidade Universitária, 21941-913 Rio de Janeiro, RJ, Brazil

Received 31 July 2014; Accepted 16 October 2014

Copyright © 2014 Juliana Maya Monteiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. A. Neuschwander-Tetri, “Fatty liver and the metabolic syndrome,” Current Opinion in Gastroenterology, vol. 23, no. 2, pp. 193–198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. D. G. Tiniakos, “Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems,” European Journal of Gastroenterology & Hepatology, vol. 22, no. 6, pp. 643–650, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Poynard, V. Ratziu, F. Charlotte et al., “Diagnostic value of biochemical markers (Nash Test) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease,” BMC Gastroenterology, vol. 6, article 34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Angulo, J. M. Hui, G. Marchesini et al., “The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD,” Hepatology, vol. 45, no. 4, pp. 846–854, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Wieckowska, A. J. McCullough, and A. E. Feldstein, “Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future,” Hepatology, vol. 46, no. 2, pp. 582–589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Ludwig, T. R. Viggiano, D. B. McGill, and B. J. Ott, “Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease,” Mayo Clinic Proceedings, vol. 55, no. 7, pp. 434–438, 1980. View at Google Scholar · View at Scopus
  7. C. A. Matteoni, Z. M. Younossi, T. Gramlich, N. Boparai, and A. J. McCullough, “Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity,” Gastroenterology, vol. 116, no. 6, pp. 1413–1419, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. E. M. Brunt, C. G. Janney, A. M. Di Bisceglie, B. A. Neuschwander-Tetri, and B. R. Bacon, “Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions,” The American Journal of Gastroenterology, vol. 94, no. 9, pp. 2467–2474, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. D. E. Kleiner, E. M. Brunt, M. van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. E. M. Brunt, D. E. Kleiner, L. A. Wilson, P. Belt, and B. A. Neuschwander-Tetri, “Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings,” Hepatology, vol. 53, no. 3, pp. 810–820, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Bedossa, C. Poitou, N. Veyrie et al., “Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients,” Hepatology, vol. 56, no. 5, pp. 1751–1759, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Landis and G. G. Koch, “The measurement of observer agreement for categorical data,” Biometrics, vol. 33, no. 1, pp. 159–174, 1977. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  13. Z. M. Younossi, M. Stepanova, N. Rafiq et al., “Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality,” Hepatology, vol. 53, no. 6, pp. 1874–1882, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. Sanyal, E. M. Brunt, D. E. Kleiner et al., “Endpoints and clinical trial design for nonalcoholic steatohepatitis,” Hepatology, vol. 54, no. 1, pp. 344–353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. E. M. Brunt, D. E. Kleiner, C. Behling et al., “Misuse of scoring systems,” Hepatology, vol. 54, no. 1, pp. 369–370, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. D. E. Kleiner and E. M. Brunt, “Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research,” Seminars in Liver Disease, vol. 32, no. 1, pp. 3–13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Hjelkrem, C. Stauch, J. Shaw, and S. Harrison, “Validation of the non-alcoholic fatty liver disease activity score,” Alimentary Pharmacology & Therapeutics, vol. 34, no. 2, pp. 214–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Chalasani, L. Wilson, D. E. Kleiner, O. W. Cummings, E. M. Brunt, and A. Ünalp, “Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 48, no. 5, pp. 829–834, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Pournik, S. M. Alavian, L. Ghalichi et al., “Inter-observer and intra-observer agreement in pathological evaluation of non-alcoholic fatty liver disease suspected liver biopsies,” Hepatitis Monthly, vol. 14, no. 1, Article ID e15167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Lackner, M. Gogg-Kamerer, K. Zatloukal, C. Stumptner, E. M. Brunt, and H. Denk, “Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis,” Journal of Hepatology, vol. 48, no. 5, pp. 821–828, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Pais, F. Charlotte, L. Fedchuk et al., “A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver,” Journal of Hepatology, vol. 59, no. 3, pp. 550–556, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Gramlich, D. E. Kleiner, A. J. McCullough, C. A. Matteoni, N. Boparai, and Z. M. Younossi, “Pathologic features associated with fibrosis in nonalcoholic fatty liver disease,” Human Pathology, vol. 35, no. 2, pp. 196–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Fujii and N. Kawada, “Inflammation and fibrogenesis in steatohepatitis,” Journal of Gastroenterology, vol. 47, no. 3, pp. 215–225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Miyaaki, T. Ichikawa, K. Nakao et al., “Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis,” Liver International, vol. 28, no. 4, pp. 519–524, 2008. View at Publisher · View at Google Scholar · View at Scopus